EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Unraveling cholesterol metabolism in multiple sclerosis: Gender-specific patterns and predictive biomarkers

Laura Moles, Maurice Konings, Rocío Del Carmen Bravo-Miana, Hirune Crespillo-Velasco, Álvaro Prada, Tamara Castillo-Triviño, Jogchum Plat, David Otaegui

Neurobiology of Disease · 2025

DOI: 10.1016/j.nbd.2025.107143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Laura Moles und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biogipuzkoa Health Research Institute, Neuroimmunology Group, 20014 San Sebastián, Spain; Center for Biomedical Research Network in Neurodegenerative…. Hauptthemen laut MEDLINE: Cholesterol, Multiple Sclerosis, Sex Characteristics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Health Carlos III (ISCIII), the Sara Borrell program, Carlos III Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple Sclerosis (MS) is a chronic, immune-mediated disease characterized by demyelination, axonal damage, and cognitive impairment. Emerging evidence suggests that disruptions in cholesterol metabolism contribute to MS progression, as cholesterol and related sterols play a crucial role in immune regulation and myelin composition. This study analyzed cholesterol, non cholesterol sterols (NCS), and oxysterols in serum and cerebrospinal fluid (CSF) from 127 individuals with clinically isolated syndrome, relapsing-remitting MS or primary progressive MS as well as 49 individuals wirh other neurological disorders (OND). Additionally, serum Neurofilament light chain (NfL), a marker of axonal damage, was measured. Results revealed significant alterations in cholesterol metabolism in MS. Serum cholesterol and cholesterol synthesis markers were elevated, while CSF cholesterol levels were reduced, indicating a contrasting pattern between peripheral and central cholesterol metabolism. Cholesterol absorption was notably decreased in individuals with MS. NfL levels mirrored the pattern observed in serum cholesterol but were inversely related to CSF cholesterol, suggesting a potential link between axonal damage and disease progression. Importantly, serum-CSF correlation varied by MS type and gender. The observed gender-specific differences in cholesterol metabolism may contribute to our understanding of the distinct disease manifestations in men and women and should be taken into account in both the diagnosis and treatment of MS. The findings also suggest that impaired cholesterol synthesis in the brain may play a role in MS pathology, with reduced CSF cholesterol levels potentially serving as a marker of demyelination. Furthermore, specific serum (oxy)sterols emerged as promising biomarkers for MS diagnosis and progression. Together, these insights improve our understanding of MS and may support the identification of novel diagnostic markers and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolMultiple SclerosisSex CharacteristicsHumansMaleBiomarkersFemaleAdultMiddle AgedOxysterolsNeurofilament Proteins

Stichwörter der Autor:innen

BiomarkersCholesterolMultiple sclerosisOxysterolsPhytosterols

Substanzen

CholesterolBiomarkersOxysterolsNeurofilament Proteinsneurofilament protein L

Autor:innen und Institutionen

  • Biogipuzkoa Health Research Institute, Neuroimmunology Group, 20014 San Sebastián, Spain; Center for Biomedical Research Network in Neurodegenerative Diseases (CIBER-CIBERNED-ISCIII), 28029 Madrid, Spain. Electronic add…
  • Department of Nutrition and Movement Sciences, Institute for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, the Netherlands.
  • Biogipuzkoa Health Research Institute, Neuroimmunology Group, 20014 San Sebastián, Spain; Center for Biomedical Research Network in Neurodegenerative Diseases (CIBER-CIBERNED-ISCIII), 28029 Madrid, Spain.
  • Biogipuzkoa Health Research Institute, Neuroimmunology Group, 20014 San Sebastián, Spain.
  • Immunology Department, Donostia University Hospital, Osakidetza Basque Health Service, 20014 San Sebastián, Spain.
  • Biogipuzkoa Health Research Institute, Neuroimmunology Group, 20014 San Sebastián, Spain; Center for Biomedical Research Network in Neurodegenerative Diseases (CIBER-CIBERNED-ISCIII), 28029 Madrid, Spain; Neurology Depa…

Förderung

  • National Institute of Health Carlos III (ISCIII)
  • the Sara Borrell program
  • Carlos III Health Institute

Zitieren

APA

Moles, L., Konings, M., Bravo-Miana, R. D. C., Crespillo-Velasco, H., Prada, Á., Castillo-Triviño, T., Plat, J., & Otaegui, D. (2025). Unraveling cholesterol metabolism in multiple sclerosis: Gender-specific patterns and predictive biomarkers. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.107143

Vancouver

Moles L, Konings M, Bravo-Miana RDC, Crespillo-Velasco H, Prada Á, Castillo-Triviño T, et al. Unraveling cholesterol metabolism in multiple sclerosis: Gender-specific patterns and predictive biomarkers. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2025.107143

BibTeX
@article{Moles2025,
  author = {Moles, Laura and Konings, Maurice and Bravo-Miana, Rocío Del Carmen and Crespillo-Velasco, Hirune and Prada, Álvaro and Castillo-Triviño, Tamara and Plat, Jogchum and Otaegui, David},
  title = {Unraveling cholesterol metabolism in multiple sclerosis: Gender-specific patterns and predictive biomarkers},
  journal = {Neurobiology of Disease},
  year = {2025},
  doi = {10.1016/j.nbd.2025.107143}
}
Kostenlos starten →